App-Quantinova.ai

CORONARY OBSTRUCTION FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: INSIGHTS ON BASELINE PATIENT- CHARACTERISCTICS, MANAGEMENT AND CLINICAL OUTCOMES

Henrique Barbosa Ribeiro - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

INFLUENCE OF SMOKING ON THE ANTIPLATELET EFFECT OF CLOPIDOGREL DIFFERS ACCORDING TO DOSING STRATEGY: INSIGHTS FROM THE GRAVITAS TRIAL

Grant W. Reed - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

RISK FACTORS FOR VERY LATE STENT THROMBOSIS AFTER SIROLIMUSELUTING STENT IMPLANTATION AND IMPACT OF DISCONTINUATION OF THIENOPYRIDINE THERAPY

Yasushi Fuku - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

OPTIMIZING P2Y12RECEPTOR INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS AFTER PCI USING PLATELET FUNCTION TESTING: IMPACT OF PRASUGREL VERSUS HIGHDOSE CLOPIDOGREL

Daniel Aradi - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

TRANSCATHETER VALVE IMPLANTATION CAN ALTER THE FLUID FLOW FIELDS IN THE AORTIC SINUSES AND ASCENDING AORTA: AN IN VITRO STUDY

Neelakantan Saikrishnan - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A FLOWCYTOMETRIC ANALYSIS OF THE INHIBITION OF PLATELET REACTIVITY WITH NITRITE REDUCTION BY DEOXYGENATED ERYTHROCYTES

Krittapoom Akrawinthawong - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitric oxide

NATIONAL TRENDS IN PULMONARY EMBOLISM HOSPITALIZATION RATES AND OUTCOMES FOR MEDICARE BENEFICIARIES, 19992010

Karl E. Minges - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

THE EFFECT OF INFERIOR VENA CAVA FILTER PLACEMENT ON INHOSPITAL OUTCOMES IN PATIENTS WITH LOWER EXTREMITY DEEP VEIN THROMBOSIS

Chad Joseph Zack - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Methadone hydrochloride

COMPARATIVE OUTCOMES OF CATHETERDIRECTED THROMBOLYSIS IN LOW VOLUME CENTERS VERSUS HIGH VOLUME CENTERS IN THE TREATMENT OF LOWER EXTREMITY PROXIMAL DEEP VEIN THROMBOSIS

Riyaz Bashir - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

COMPARATIVE OUTCOMES OF CATHETERDIRECTED THROMBOLYSIS WITH ANTICOAGULATION VERSUS ANTICOAGULATION ALONE IN CANCER PATIENTS WITH DEEP VENOUS THROMBOSIS

Yevgeniy Brailovsky - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

RANDOMIZED TRIAL OF TENECTEPLASE OR PLACEBO WITH LOW MOLECULAR WEIGHT HEPARIN FOR ACUTE SUBMASSIVE PULMONARY EMBOLISM: ASSESSMENT OF PATIENTORIENTED CARDIOPULMONARY OUTCOMES AT THREE MONTHS

Jeffrey Kline - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Tenecteplase

IRON DEFICIENCY: THE RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM

Ewa Anita Jankowska - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

THE UTILITY OF ENDOTHELIAL FUNCTION AS ASSESSED BY REACTS HYPEREMIAPERIPHERAL ARTERIAL TNONOMETRY IN PREDICTING DEEP VENOUS THROMBOSIS AFTER ORTHOPEDIC SURGERY

Hiroyuki Suzuki - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

CAN THE BLEEDING ACADEMIC RESEARCH CONSORTIUM (BARC) CLASSIFICATION BE APPLIED TO PULMONARY EMBOLISM?

Nicolas F. Meneveau - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

LOW EJECTION FRACTION: COMMON LINK BETWEEN ARTERIAL AND VENOUS EVENTS IN PATIENTS UNDERGOING PCI

Moshe Vardi - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

ZoMaxx

CHARACTERIZATION OF THE MYOCARDIAL INFARCTION ENDPOINTS, IMPACT OF EVENT ADJUDICATION, AND TICAGRELOR EFFECTS IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL

Kenneth W. Mahaffev - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

OBESITY IN YOUNG ADULT MEN AND RISK OF TYPE II DIABETES, CARDIOVASCULAR MORBIDITY, OR DEATH BEFORE 55 YEARS OF AGE: A DANISH 33-YEAR FOLLOW-UP STUDY

Morten Schmidt - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

OUTCOMES OF ANTI-PLATELET THERAPY FOR ACS AND NON-ACS PATIENTS DIRECTED BY POST-PCI PLATELET FUNCTION TESTING IN A REAL WORLD SETTING

Elad Asher - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

ANTICOAGULATION THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

Stacey Knight - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

PREDICTORS OF STENT THROMBOSIS WITH DRUG-ELUTING STENT IN JAPANESE POPULATION: KICS REGISTRY

Masahide Nagano - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

Filters

7277 Abstracts